EU HTA & EUnetHTA21 – The pathway for implementation of the EU HTA system in 2025 – helping companies prepare for submission
28. Mar 2022 — Register now
Join EUNetHTA, EUCOPE and MAP Patient Access as they discuss the implementation of the EU HTA system in 2025. This webinar will help attendees to:
- Understand details about the stepwise entry into force of the EU HTA starting in January 2025
- Learn how EUnetHTA21 will develop the methodology and procedural rules until 2025
- Understand details about the EUnetHTA21 pilots and the benefits for companies to participate
- Learn about how companies can seek Scientific Advice for their submissions and dossiers
- Understand how the EU HTA will be integrated into national P&R decision making
- Understand how the comparators & endpoints will be selected for the multinational clinical assessment
- Learn how your company can benefit from the joint approach
- Understand the pricing implications for the EU4 countries and the UK
You can email questions to firstname.lastname@example.org.
Please note, this webinar is only available to BioPharma and MedTech companies.